Canada greenlights Moderna Ebola trials
The Canadian Ministry of Health has announced its approval to initiate clinical trials of Moderna's vaccine against the Bondoiboigu strain of the Ebola virus. The first phase of the trials will assess the safety of the vaccine, the range of safe dosages, and potential side effects, with healthy participants receiving a dose to test the production of antibodies against the strain. Although there are currently no cases in Canada, these trials aim to develop an effective vaccine against this variant, which is currently causing an outbreak in the Democratic Republic of Congo. The development of vaccines based on mRNA technology is part of Moderna's strategy to combat the potential spread of Ebola.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)